Quantifying heterogeneity in a meta-analysis
- PMID:12111919
- DOI: 10.1002/sim.1186
Quantifying heterogeneity in a meta-analysis
Abstract
The extent of heterogeneity in a meta-analysis partly determines the difficulty in drawing overall conclusions. This extent may be measured by estimating a between-study variance, but interpretation is then specific to a particular treatment effect metric. A test for the existence of heterogeneity exists, but depends on the number of studies in the meta-analysis. We develop measures of the impact of heterogeneity on a meta-analysis, from mathematical criteria, that are independent of the number of studies and the treatment effect metric. We derive and propose three suitable statistics: H is the square root of the chi2 heterogeneity statistic divided by its degrees of freedom; R is the ratio of the standard error of the underlying mean from a random effects meta-analysis to the standard error of a fixed effect meta-analytic estimate, and I2 is a transformation of (H) that describes the proportion of total variation in study estimates that is due to heterogeneity. We discuss interpretation, interval estimates and other properties of these measures and examine them in five example data sets showing different amounts of heterogeneity. We conclude that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity. One or both should be presented in published meta-analyses in preference to the test for heterogeneity.
Copyright 2002 John Wiley & Sons, Ltd.
Similar articles
- Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.Bowden J, Tierney JF, Copas AJ, Burdett S.Bowden J, et al.BMC Med Res Methodol. 2011 Apr 7;11:41. doi: 10.1186/1471-2288-11-41.BMC Med Res Methodol. 2011.PMID:21473747Free PMC article.
- [Application of Stata software to test heterogeneity in meta-analysis method].Wang D, Mou ZY, Zhai JX, Zong HX, Zhao XD.Wang D, et al.Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jul;29(7):726-9.Zhonghua Liu Xing Bing Xue Za Zhi. 2008.PMID:19031771Chinese.
- Alternative measures of between-study heterogeneity in meta-analysis: Reducing the impact of outlying studies.Lin L, Chu H, Hodges JS.Lin L, et al.Biometrics. 2017 Mar;73(1):156-166. doi: 10.1111/biom.12543. Epub 2016 May 11.Biometrics. 2017.PMID:27167143Free PMC article.
- The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses.Melsen WG, Bootsma MC, Rovers MM, Bonten MJ.Melsen WG, et al.Clin Microbiol Infect. 2014 Feb;20(2):123-9. doi: 10.1111/1469-0691.12494.Clin Microbiol Infect. 2014.PMID:24320992Review.
- Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses.Engels EA, Schmid CH, Terrin N, Olkin I, Lau J.Engels EA, et al.Stat Med. 2000 Jul 15;19(13):1707-28. doi: 10.1002/1097-0258(20000715)19:13<1707::aid-sim491>3.0.co;2-p.Stat Med. 2000.PMID:10861773Review.
Cited by
- Efficacy of Colchicine for Prevention of Stroke and Adverse Cardiovascular Events: A Meta-analysis of 16 Randomized Controlled Trials.Jaiswal V, Deb N, Hanif M, Wajid Z, Nasir YM, Naz S, Kalra K, Qaiser S, Shrestha AB, Bandyopadhyay D, Mattumpuram J.Jaiswal V, et al.Am J Cardiovasc Drugs. 2025 Jan;25(1):83-93. doi: 10.1007/s40256-024-00689-7. Epub 2024 Oct 26.Am J Cardiovasc Drugs. 2025.PMID:39460903
- Prevalence of humanSchistosoma mansoni infection in endemic regions (2010-2024): a systematic review and meta-analysis.Tavakoli Pirzaman A, Sepidarkish M, Alizadeh F, Al-Obidy S, Ebrahimi P, Kianifard N, Sheikhi Nooshabadi M, Jafari Tadi M, Zolfaghari Dehkharghani M, Mousavi S, Rezapour N, Mohammadnia S, Fazlollahpour Naghibi A, Bagheri K, Asghari MH, Bayani M, Rollinson D, Gasser RB, Rostami A.Tavakoli Pirzaman A, et al.EClinicalMedicine. 2024 Oct 4;77:102855. doi: 10.1016/j.eclinm.2024.102855. eCollection 2024 Nov.EClinicalMedicine. 2024.PMID:39430613Free PMC article.
- Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients: Synthesis of Evidence.Bellos I, Lagiou P, Benetou V, Marinaki S.Bellos I, et al.J Clin Med. 2024 Oct 17;13(20):6181. doi: 10.3390/jcm13206181.J Clin Med. 2024.PMID:39458136Free PMC article.Review.
- Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy.Bertucci F, Guille A, Lerebours F, Ceccarelli M, Syed N, Adélaïde J, Finetti P, Ueno NT, Van Laere S, Viens P, De Nonneville A, Goncalves A, Birnbaum D, Callens C, Bedognetti D, Mamessier E.Bertucci F, et al.J Transl Med. 2024 Oct 27;22(1):969. doi: 10.1186/s12967-024-05790-8.J Transl Med. 2024.PMID:39465437Free PMC article.
- Association of sugar consumption with risk of depression and anxiety: a systematic review and meta-analysis.Xiong J, Wang L, Huang H, Xiong S, Zhang S, Fu Q, Tang R, Zhang Q.Xiong J, et al.Front Nutr. 2024 Oct 16;11:1472612. doi: 10.3389/fnut.2024.1472612. eCollection 2024.Front Nutr. 2024.PMID:39479195Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Other Literature Sources
Medical